Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
Gordon J. Freeman(Harvard University), Tasuku Honjo(Kyoto University), Taku Okazaki(Tokushima University), Lori Fitz(Inflammation Research Foundation), Karen Bourque, Heidi F. Horton, Laura Carter, Michael Bowman, Clive R. Wood, Nelly Malenkovich(Harvard University), Andrew J. Long, Yoshiko Iwai(Nippon Medical School), Michael C. Byrne, Hiroyuki Nishimura(Kyoto University), Tatyana Chernova(University of Cambridge), Lynette A. Fouser, Beatriz M. Carreno(California University of Pennsylvania), Vincent Ling, Mary Collins
Cited by 5,232
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
PD-1 and PD-1 ligands: from discovery to clinical application
|International Immunology|2007|1.3k
ICOS is critical for CD40-mediated antibody class switching
|Nature|2001|644